Skip to main content

Table 1 Baseline characteristics of MDS patients and healthy controls

From: Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome

 

MDS

Controls

aAge (years)

43.7 (33–59)

44.3 (37–67)

Male/Female

11/9

8/8

aSerum iron [μmol/L]

22.3 (11.4-43.3)

b8.5-28

aSerum ferritin [μg/L]

641.2 (8.9-1907.3)

b15-150

  1. aThe data are depicted as averages with ranges. bReference interval.
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us